These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16467677

  • 1. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.
    Costello P, Bakri SJ, Beer PM, Singh RJ, Falk NS, Peters GB, Melendez JA.
    Retina; 2006 Feb; 26(2):191-5. PubMed ID: 16467677
    [Abstract] [Full Text] [Related]

  • 2. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP, Caudle D, Aronowicz JD, Shine WE.
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [Abstract] [Full Text] [Related]

  • 3. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
    Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Holekamp NM, Thomas MA, Mieler WF, Chi J, Prince RA.
    Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810
    [Abstract] [Full Text] [Related]

  • 4. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
    Kim DH, Stark WJ, O'Brien TP, Dick JD.
    Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
    [Abstract] [Full Text] [Related]

  • 5. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
    Lai WW, Chu KO, Chan KP, Choy KW, Wang CC, Tsang CW, Pang CP.
    Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
    [Abstract] [Full Text] [Related]

  • 6. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.
    Ong-Tone L.
    J Cataract Refract Surg; 2007 Jan; 33(1):59-62. PubMed ID: 17189794
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
    Hariprasad SM, Mieler WE, Shah GK, Blinder KJ, Apte RS, Holekamp NM, Thomas MA, Chi J, Prince RA.
    Trans Am Ophthalmol Soc; 2004 Jan; 102():149-55; discussion 155-7. PubMed ID: 15747753
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
    Chung JL, Lim EH, Song SW, Kim BY, Lee JH, Mah FS, Seo KY.
    Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
    [Abstract] [Full Text] [Related]

  • 16. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.
    Solomon R, Donnenfeld ED, Perry HD, Snyder RW, Nedrud C, Stein J, Bloom A.
    Ophthalmology; 2005 Mar; 112(3):466-9. PubMed ID: 15745775
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.